A leading Texas biotechnology company, Mirna Therapeutics, Inc. has announced the initiation of Phase 1 clinical trials of MRX34 in patients with unresectable primary liver cancer or metastatic cancer with liver involvement.
http://bionews-tx.com/news/2013/05/15/mirna-therapeutics-is-first-to-advance-microrna-into-the-clinic-for-cancer/
No comments:
Post a Comment